spacer

CDC HomeHIV/AIDS > Questions and Answers > Q&A: CDC’s Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention

  Topics
space
arrow African Americans
space
arrow Basic Information
space
arrow Funding
space
arrow Global HIV/AIDS
space
arrow Hispanics/Latinos
space
arrow Men Who Have Sex with Men (MSM)
space
arrow Statistics & Surveillance
space
arrow Testing
space
arrow Women
space
arrow More Topics...
space
  Resources by Format
space
arrow Questions & Answers
space
arrow Fact Sheets
space
arrow Brochures
space
arrow Slide Sets
space
arrow Podcasts
space
arrow Software
space
arrow Journal Articles
space
arrow Reports
space
arrow Recommendations & Guidelines
space
arrow Other Documents
space
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
Q&A: CDC’s Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention: Community Involvement in These Studies
spacer
spacer

What is being done to solicit input from the communities in which these trials will be conducted?

CDC will continue to work closely with community partners at each research site to ensure active community participation during the planning and implementation of these trials.

Botswana: In Botswana, community advisory boards have been established at each site. The boards comprise representatives from local governments (elected and traditional), as well as community members and representatives from key stakeholder organizations. Participant advisory boards have also been established. These groups will provide input to researchers throughout the trial. Additionally, community liaisons at each site conduct outreach to community organizations and respond to any questions or concerns.

Thailand: In Thailand, a community relations committee, composed of injecting drug users from each of the 17 drug treatment clinics, family members, and representatives of local community organizations, meets regularly and provides advice to trial staff on all aspects of trial design, implementation, and trial conduct.

United States: In the United States, all three sites have established active community advisory boards that are consulted regularly about trial procedures and educational materials for potential participants. Members of these boards will provide advice throughout the trials. Community educators at each site work to ensure that community organizations are updated on trial progress and to respond to questions or concerns.

In addition to the regular input received by these established committees, broader outreach and consultations with advocates and community-based organizations representing populations at risk for HIV have been, and will continue to be, held, as needed, to address plans for HIV prevention research and programs.

Back to Questions

spacer
Last Modified: July 30, 2008
Last Reviewed: July 30, 2008
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services